Opthea (OPT) Competitor Comparison
We are evaluating the key criteria listed to compare Opthea (OPT) against its competitors in the Biotechnology industry.
Market Capitalization
202 / 368Gross Profits
143 / 278Total Revenue
256 / 300EBITDA
244 / 337Free Cashflow
269 / 352Quick Ratio
181 / 357Earnings per Share
250 / 359Dividend yield
0 / 6Total Cash
224 / 358Performance 3 years
173 / 368Performance 5 years
210 / 368Performance 10 years
180 / 368Linearity 3 years
92 / 368Linearity 5 years
196 / 368Linearity 10 years
176 / 368Total Rank
343 / 368Dividend Rank
229 / 368Valuation Rank
360 / 368Piotroski Rank
301 / 368Muliplier Rank
172 / 368Free Cashflow - OPT ranking 269 / 352
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.